Leadership

Phillip B.B. Moheno, PhD, Founder, Acting President, and Chief Scientist

In addition to more than 20 years of research experience into the anticancer properties of pterins, Dr. Moheno has more than seven years experience as Vice President of Intellectual Property and Partnerships for Verne Mendel Medical Corp. and as Chief Executive Officer and Principal Investigator for San Diego Research.

Dr. Moheno's research and development activities in cancer pharmacology have led to the awarding of three US patents with another application in process. Dr. Moheno has over 15 years of experience as an undergraduate professor in biochemistry and biology, most recently as adjunct professor of chemistry at San Diego State University and California State University San Marcos. Dr. Moheno led the development of two broad lines of proprietary antineoplastic compounds, the result of over 30 years of work at the Salk Institute for Biological Studies, the La Jolla Cancer Research Foundation, the University of California Los Angeles, the California State Universities of Bakersfield and San Diego, and San Diego Research. Dr. Moheno holds a BS in biochemistry from the University of California Los Angeles and a PhD from the University of California Santa Barbara.

Edgar Berkey, PhD, Founder, Acting Chief Executive Officer and Board Chair

Previous experience: Vice President, Research and Development, and Chief Quality Officer of Concurrent Technologies Corporation, a large national applied research organization in the energy, environmental, and national defense fields; President and Co-Founder of the Center for Hazardous Materials Research, and the National Environmental Technology Applications Corporation in Pittsburgh, PA; founder and President of SynCo Consultants, Inc., Vice President of Energy Impact Associates; Manager and Senior Research Scientist at Westinghouse Research Laboratories; education includes a PhD in engineering physics from Cornell, a BS in chemical engineering from Stanford, and the Executive MBA Program at the University of Pittsburgh.

Sandy Wei, VP of Corporate Development

Global experience in the medical device and pharmaceutical industries in: business development and expansion, product development, market definition and development, purchasing management, international sales management, supply chain management, major licensing, international regulatory compliance (CE Mark, FDA510K, China SFDA, and Singapore HAS), import matters and client maintenance with the following: Origin Biosciences Nanjing, China, Founder & VP of Business Development, drug discovery and development services in China, ultrasound imaging technology; Bridge Laboratories, Gaithersburg, MD., Business Development Manager, contract biotech and pharmaceutical research organization; ProBioSensor, San Diego, CA, Sales & Project Manager, medical device company and international consulting firm; New Business Venture Consultant, Taipei, Taiwan, start-up consulting for prospective new China and Southeast Asia business venture with Taiwan ownership; Oncoprobe Biotech, Taipei, Taiwan, diagnostic test manufacturer. Wei holds an MBA in International Business and Marketing, from Seattle University, Seattle, WA; Agricultural Chemistry National Taiwan University, Taiwan, and is fluent in English, Mandarin and Japanese.

Alan R. Bird, Chief Business Officer

Chief Financial Officer, Controller for the Lakeway Company, a large, multi-faceted resort in Austin, Texas; Controller for Orton Investments, an office building development company, and Controller for Southwest Real Estate Group, a commercial properties leasing and management company in Texas, financial manager for Learning Ventures, a Denver multi-media software development company, Director of Business Development for Global Tax Services, a division of Quark, Inc., which provided online services for CPA firms. Bird holds a Bachelors in Business Administration from the University of Texas at Austin.

Board of Directors

• Edgar Berkey, Ph.D. – Chairman of the Board and Acting CEO

• Phillip B.B. Moheno, Ph.D. – Acting President & Chief Scientist

The SanRx Scientific Advisory Board

Boris Minev
MD Head of Tumor Immunology and Research Scientist, UCSD Cancer Center

Dr. Minev has done significant work in the field of tumor immunology and immunotherapy, and development of synthetic and recombinant vaccines for cancer, including new approaches to immunotherapy of breast and prostate cancer and melanoma.

Ewa Carrier, MD
Associate Professor, Medicine & Hematologic Malignancies, UCSD Cancer Center

Dr. Carrier's research focuses on stem cell biology and its transplantation to cancer and organ repair, She focuses on the properties of pluripotent stem cells, including embryonic, fetal, mesenchymal and bone marrow stem cells, to generate differentiation protocols for the treatment of a variety of disorders.

Dietmar Fuchs, PhD
Associate Professor of Medical Chemistry, Innsbruck Medical University, Austria

Dr Fuchs is co-director of the Ludwig Boltzmann Institute of AIDS-Research in Innsbruck and holds a PhD in Chemistry from the Leopold Franzens University of Innsbruck. Dr Fuchs has authored over 100 publications in the field of clinical immunology addressing key disease areas such as cancer, AIDS and Alzheimer's. He is an executive member of the International Society of Pteridinology.

Wolfgang Pfleiderer, PhD
Professor of Chemistry, Universities of Stuttgart and Konstanz in Germany

Professor Pfleiderer has over 50 years of experience in academia, and is considered a world renowned expert in pteridine and heterocyclic chemistry. Professor Pfleiderer is President of the International Societies of Heterocyclic Chemistry, Pteridinology and Nucleic Acid Research

Additional members of the SanRx scientific advisory team:

Christiana Winkler, PhD - Innsbruck Medical University (Austria), Medical Chemistry

Arnold L. Rheingold, PhD - UC San Diego, Chemistry & Biochemistry

Antonio G. DiPasquale, PhD - UC Berkeley College of Chemistry

James C. Ryan, MD - UC San Francisco, Immunology

Ana Maria Barral, PhD - SanRx Consultant

Careers

SanRx Pharmaceuticals is an dynamic and entrepreneurial company where high energy, enthusiasm, teamwork and professionalism drive our research innovations and development successes.

The company is headquartered in San Diego, California. We have collaborations in several other locations in the US and Europe.

SanRx is an equal opportunity employer and does not discriminate on the basis of race, color, religion, sex, national origin, age, handicapping condition, marital status, or other protected status covered by applicable government regulations.